Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The first non-surgical repair for Pelvic Organ Prolapse

Project description

Incision-free treatment of pelvic organ prolapse

Pelvic organ prolapse (POP) is a medical condition that occurs when the muscles and tissues that support the pelvic organs (uterus, bladder, rectum) become weakened or damaged, leading to the shift of pelvic organs into the vaginal canal. Despite the high prevalence of POP, the only means of treatment is surgical intervention which is associated with prolonged recovery and pain. Funded by the European Innovation Council, the apyx project aims to promote a medical device for the non-surgical treatment of early-stage POP. The device assists the anchoring of sutures to the ligaments of the pelvic floor without incisions, under local anaesthetic within only 20 minutes.

Objective

Pelvic Organ Prolapse (POP) affects nearly 50% of women over 40 years old globally. 89% of the cases seek treatment for symptomatic early stage prolapse. Despite the high prevalence and the progression of POP over time, patients currently cannot be offered a repair solution until the condition worsens enough for surgical intervention. However, the surgical interventions of prolapse have several side effects like prolonged recovery, pelvic pain and relapses of POP. Escala Medical has developed a minimally invasive and incision-free repair intervention for early-stage POP repair - Apyx. Apyx is the first medical device for treating early stage prolapse, regaining quality of life and prevention of prolapse deterioration for the vast majority, currently un-addressed, POP sufferers. The EIC project will finalize the development of Apyx, conduct clinical trials, and support scale-up and commercialization activities.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-ACCELERATOR-01

See all projects funded under this call

Coordinator

ESCALA MEDICAL LTD
Net EU contribution
€ 2 500 000,00
Address
17 MISGAV
2017400 MISGRAV
Israel
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 5 067 216,25